Full-Time

Senior Business Analyst

Apptio

Posted on 4/15/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

No salary listed

Senior

Bengaluru, Karnataka, India

Flexible work environment, including hybrid working

Category
Project Management
Business & Strategy
Required Skills
JavaScript
JIRA
Requirements
  • Minimum 2 years of work experience in a fast-paced environment.
  • Ability to manage multiple business units/ leads and deliverables at any given time through effective time management and planning
  • Strong work ethic and the ability to work with diverse teams across different time zones
  • Someone eager to grow their IT skills in a fast-paced IT environment. A highly motivated and self-guided individual who can receive a task and see it through with minimal supervision
  • Ability to analyze situations, form ideas, and get creative to provide solutions. Pride yourself on strong communication, relationship-building, and facilitation skills.
  • Postgraduate degree in MBA with a finance and operations background
  • Should hold a bachelor’s degree (B.E/B.Tech) in Computer Science, Information Technology, or a relevant field.
  • Knowledge or experience in SAFe (Scaled Agile Framework) will have an added advantage.
  • Should have good hands-on experience in Java Script, JSON and API.
  • Apptio Targetprocess certification an added advantage.
Responsibilities
  • Implement Apptio Targetprocess instance and partner with business functions to gain user adoption
  • Collaborate with users and stakeholders to drive toward desired outcomes aligning with the continuous requirement.
  • Act as the primary point of contact for the business users and work towards implementation & support.
  • Manage the engagement with the leads to correctly structure, and deploy new feature and solution of Apptio.
  • Update and add new features and solution of Apptio Targetprocess.
  • Gather customer feedback and work with the Product Management team to recommend how to improve product usability
  • Troubleshoot customer issues and collaborate with support and development teams to resolve.
  • Solution Management - install/configure pre-defined and custom Apptio Targetprocess solutions aligning with department/ unit and ART needs
  • Create custom Apptio Targetprocess views, reports, and dashboards
  • Configure Apptio Targetprocess process parameters and settings
  • Create custom Apptio Targetprocess automation rules and metrics for event-based customization
  • Import customer data
  • Configure integrations with 3rd party products Jira, Azure DevOps, etc
  • Performs other duties as required
Desired Qualifications
  • Experience working in a global environment
  • Apptio Targetprocess certification is an added advantage

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline that includes 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda's products are aimed at healthcare providers, hospitals, and patients around the world, and the company collaborates with about 41,000 suppliers to ensure the production and distribution of its medicines. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that the needs of patients guide its operations. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health. The company's goal is to provide life-changing treatments while also addressing environmental risks that could affect public health.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.